4-ANPP CRM cas: 31409-26-7 is a synthetic compound with various applications in the pharmaceutical and industrial sector. It is a white crystalline powder that has gained widespread attention due to its potential effects in the human body. This article aims to provide comprehensive information about 4-ANPP CRM cas: 31409-26-7, including its chemical name, molecular formula, health benefits, potential effects, mechanism of action, safety, side effects, dosing information, and conclusion.
Chemical Name:
4-ANPP CRM cas: 31409-26-7, also known as 4-anilino-N-phenethylpiperidine, is an organic compound with the molecular formula C19H24N2.
Molecular Formula:
C19H24N2
Formula Weight:
284.41 g/mol
CAS No:
31409-26-7
Top Ten Keywords from Google and Synonyms:
NPP
4-Anilino-N-phenethylpiperidine
1-(4-Anilinopiperidin-1-yl)propan-2-amine
C19H24N2
Synthetic Opioid
Fentanyl analogue
Potent Analgesic
Pain Management
Narcotic
Chemical Reagent
1-(4-Anilinopiperidin-1-yl)propan-2-amine
Fentanyl Analog
Narcotic Analgesic
Synthetic Human Opioids
Potent Painkillers
CII Controlled Substance
Prescription Narcotic
Synthetic Painkiller
Analog of Fentanyl
Designer drug
Health Benefits of 4-ANPP CRM cas: 31409-26-7:
4-ANPP CRM cas: 31409-26-7 is primarily used as a precursor for the synthesis of fentanyl analogs, which are potent analgesics used for pain management. Fentanyl analogs are used in the treatment of cancer pain, postoperative pain, and other acute and chronic pain conditions. They are also used as a replacement for other opioids such as morphine, codeine, and oxycodone.
Potential Effects:
As a fentanyl analog, 4-ANPP CRM cas: 31409-26-7 has a high potential for abuse and addiction. It produces similar effects to other opioids, such as pain relief, euphoria, drowsiness, and respiratory depression. The potency of fentanyl analogs is much greater than that of morphine, making them more dangerous and potentially lethal in overdoses.
Product Mechanism:
4-ANPP CRM cas: 31409-26-7 is a potent μ-opioid receptor agonist, which means that it binds to and activates these receptors in the brain and spinal cord. This activation leads to the inhibition of pain signals, resulting in pain relief. The activation of μ-opioid receptors also produces other effects, such as euphoria and respiratory depression.
Safety:
The use of 4-ANPP CRM cas: 31409-26-7 and fentanyl analogs should be carefully monitored due to their potential for abuse, addiction, and overdose. They are listed as Schedule II controlled substances in the United States, meaning that they have a high potential for abuse and dependence. They should only be used under the supervision of a healthcare provider.
